|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Guohong Z, Min S, Duenmei W, Songnian H,
Min L, Jinsong L, Hongbin L, Feng Z, Dongping T, Heling Y, et al:
Genetic heterogeneity of oesophageal cancer in high-incidence areas
of southern and northern China. PLoS One. 5:e96682010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jemal A, Murray T, Samuels A, Ghafoor A,
Ward E and Thun MJ: Cancer statistics, 2003. CA Cancer J Clin.
53:5–26. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tran GD, Sun XD, Abnet CC, Fan JH, Dawsey
SM, Dong ZW, Mark SD, Qiao YL and Taylor PR: Prospective study of
risk factors for esophageal and gastric cancers in the Linxian
general population trial cohort in China. Int J Cancer.
113:456–463. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Siegel R, DeSantis C, Virgo K, Stein K,
Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, et al:
Cancer treatment and survivorship statistics, 2012. CA Cancer J
Clin. 62:220–241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lupi I, Broman KW, Tzou SC, Gutenberg A,
Martino E and Caturegli P: Novel autoantigens in autoimmune
hypophysitis. Clin Endocrinol (Oxf). 69:269–278. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rodriguez A, Pèrez-González A and Nieto A:
Cellular human CLE/C14orf166 protein interacts with influenza virus
polymerase and is required for viral replication. J Virol.
85:12062–12066. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Naili MN Natasya, Hasnita CH, Shamim AK,
Hasnan J, Fauziah MI, Narazah MY, James A, Zulkiflee S, Nidzam MM
and Zilfalil BA: Chromosomal alterations in Malaysian patients with
nasopharyngeal carcinoma analyzed by comparative genomic
hybridization. Cancer Genet Cytogenet. 203:309–312. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee JW, Liao PC, Young KC, Chang CL, Chen
SS, Chang TT, Lai MD and Wang SW: Identification of hnRNPH1, NF45l,
and C14orf166 as novel host interacting partners of the mature
hepatitis C virus core protein. J Proteome Res. 10:4522–4534. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schamel K, Staeheli P and Hausmann J:
Identification of the immunodominant H-2K(k)-restricted cytotoxic
T-cell epitope in the Borna disease virus nucleoprotein. J Virol.
75:8579–8588. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huarte M, Sanz-Ezquerro JJ, Roncal F,
Ortin J and Nieto A: PA subunit from influenza virus polymerase
complex interacts with a cellular protein with homology to a family
of transcriptional activators. J Virol. 75:8597–8604. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pèrez-González A, Pazo A, Navajas R,
Ciordia S, Rodriguez-Frandsen A and Nieto A: hCLE/C14orf166
associates with DDX1-HSPC117-FAM98B in a novel
transcription-dependent shuttling RNA-transporting complex. PLoS
One. 9:e909572014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yu H, Pardoll D and Jove R: STATs in
cancer inflammation and immunity: A leading role for STAT3. Nat Rev
Cancer. 9:798–809. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ernst M and Putoczki TL: Stat3: Linking
inflammation to (gastrointestinal) tumourigenesis. Clin Exp
Pharmacol Physiol. 39:711–718. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang J, Gu Y, Wang L, Hang X, Gao Y, Wang
H and Zhang C: HUPO BPP pilot study: A proteomics analysis of the
mouse brain of different developmental stages. Proteomics.
7:4008–4015. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guo J, Wang W, Liao P, Lou W, Ji Y, Zhang
C, Wu J and Zhang S: Identification of serum biomarkers for
pancreatic adenocarcinoma by proteomic analysis. Cancer Sci.
100:2292–2301. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cui Y, Wu J, Zong M, Song G, Jia Q, Jiang
J and Han J: Proteomic profiling in pancreatic cancer with and
without lymph node metastasis. Int J Cancer. 124:1614–1621. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang W, Ou J, Lei F, Hou T, Wu S, Niu C,
Xu L and Zhang Y: C14ORF166 overexpression is associated with
pelvic lymph node metastasis and poor prognosis in uterine cervical
cancer. Tumour Biol. 37:369–379. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sobin LH, Gospodarowicz MK and Wittekind
C: TNM classification of malignant tumors. 7th edition. Oxford:
Wiley-Blackwell; 2010
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C (T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang S, Tang W, Weng S, Liu X, Rao B, Gu
J, Chen S, Wang Q, Shen X, Xue R and Dong L: Apollon modulates
chemosensitivity in human esophageal squamous cell carcinoma.
Oncotarget. 5:7183–7197. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Elvira G, Wasiak S, Blandford V, Tong XK,
Serrano A, Fan X, del Rayo Sánchez-Carbente M, Servant F, Bell AW,
Boismenu D, et al: Characterization of an RNA granule from
developing brain. Mol Cell Proteomics. 5:635–651. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Andersen JS, Wilkinson CJ, Mayor T,
Mortensen P, Nigg EA and Mann M: Proteomic characterization of the
human centrosome by protein correlation profiling. Nature.
426:570–574. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Howng SL, Hsu HC, Cheng TS, Lee YL, Chang
LK, Lu PJ and Hong YR: A novel ninein-interaction protein, CGI-99,
blocks ninein phosphorylation by GSK3beta and is highly expressed
in brain tumors. FEBS Lett. 566:162–168. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao P, Li Q, Shi Z, Li C, Wang L, Liu X,
Jiang C, Qian X, You Y, Liu N, et al: GSK-3β regulates tumor growth
and angiogenesis in human glioma cells. Oncotarget. 6:31901–31915.
2015.PubMed/NCBI
|
|
27
|
Gao Y, Liu Z, Zhang X, He J, Pan Y, Hao F,
Xie L, Li Q, Qiu X and Wang E: Inhibition of cytoplasmic GSK-3β
increases cisplatin resistance through activation of Wnt/β-catenin
signaling in A549/DDP cells. Cancer Lett. 336:231–239. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Haraguchi K, Ohsugi M, Abe Y, Semba K,
Akiyama T and Yamamoto T: Ajuba negatively regulates the Wnt
signaling pathway by promoting GSK-3beta-mediated phosphorylation
of beta-catenin. Oncogene. 27:274–284. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kong Y, Si L, Li Y, Wu X, Xu X, Dai J,
Tang H, Ma M, Chi Z, Sheng X, et al: Analysis of mTOR gene
aberrations in melanoma patients and evaluation of their
sensitivity to PI3K-AKT-mTOR pathway inhibitors. Clin Cancer Res.
22:1018–1027. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ge C, Wu S, Wang W, Liu Z, Zhang J, Wang
Z, Li R, Zhang Z, Li Z, Dong S, et al: miR-942 promotes cancer stem
cell-like traits in esophageal squamous cell carcinoma through
activation of Wnt/β-catenin signalling pathway. Oncotarget.
6:10964–10977. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
He H, Ding F, Li Y, Luo A, Chen H, Wu C
and Liu Z: Migfilin regulates esophageal cancer cell motility
through promoting GSK-3β-mediated degradation of β-catenin. Mol
Cancer Res. 10:273–281. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang W, Yan S, Liu M, Zhang G, Yang S, He
S, Bai J, Quan L, Zhu H, Dong Y and Xu N: Beta-Catenin/TCF pathway
plays a vital role in selenium induced-growth inhibition and
apoptosis in esophageal squamous cell carcinoma (ESCC) cells.
Cancer Lett. 296:113–122. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mukthavaram R, Ouyang X, Saklecha R, Jiang
P, Nomura N, Pingle SC, Guo F, Makale M and Kesari S: Effect of the
JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres.
J Transl Med. 13:2692015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhao H, Guo Y, Li S, Han R, Ying J, Zhu H,
Wang Y, Yin L, Han Y, Sun L, et al: A novel anti-cancer agent
Icaritin suppresses hepatocellular carcinoma initiation and
malignant growth through the IL-6/Jak2/Stat3 pathway. Oncotarget.
6:31927–31943. 2015.PubMed/NCBI
|
|
35
|
Chen X, Ying Z, Lin X, Lin H, Wu J, Li M
and Song L: Acylglycerol kinase augments JAK2/STAT3 signaling in
esophageal squamous cells. J Clin Invest. 123:2576–2589. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fang J, Chu L, Li C, Chen Y, Hu F, Zhang
X, Zhao H, Liu Z and Xu Q: JAK2 inhibitor blocks the inflammation
and growth of esophageal squamous cell carcinoma in vitro through
the JAK/STAT3 pathway. Oncol Rep. 33:494–502. 2015.PubMed/NCBI
|
